Besides, there has been considerable development in recent times as far as market players of probiotics for human consumption (internal or topical) is concerned. These developments are a testimony to the growing demand for probiotics for human consumption. Thereby, signaling a healthy UK Probiotics Market growth during the forecast period. To this end, it may be noted In February 2020, SkinBioTherapeutics plc, a life science company focused on skin health, announces that its wholly-owned subsidiary, AxisBiotix Limited, has signed a development agreement with Winclove Probiotics B.V., a specialist in the research, development, and manufacture of probiotic food formulations and supplements, to help manage the symptoms associated with the skin condition, psoriasis. SkinBioTherapeutics and Winclove will design and develop a probiotic blend of 'good' bacterial strains based on the modifying properties of specific bacterial species on known psoriasis disease pathways.
As of January 2020, the nutraceutical and Cannabinoid manufacturers Medlab was reportedly teaming up with UK-based distributors Cultech to expand its probiotic products among others into Europe. It is a three-year deal that will facilitate the expansion of the Australian firm’s nutraceutical section of its business whereby the customers of UK will be able to purchase its patented probiotic rehydration formulation ORSBiotic, which is a patented formulation that reduces the occurrence of diarrhea in children’s which often leads to dehydration. It is also reported to supplement electrolytes and support gastrointestinal system health. The formulation has been reported to contain the probiotic species Saccharomyces Boulardii and zinc which is expected to aid in the reduction of the occurrence of diarrhea.
Earlier in 2017, SkinBioTherapeutics, a spin-out from the University of Manchester, debuted in AIM, the London Stock Exchange’s market for smaller growing companies. It had reportedly raised funding to continue the development and accelerate clinical development of the company’s SkinBiotix technology, which encompasses products that are based on extracts of probiotic organisms. The rationale behind this development was to develop a product with probiotics that would have therapeutic action on the skin.
Segmentation
By Application
- Functional Food and Beverages
- Dietary Supplements
- Animal Feed
- Bacteria
- Lactobacilli
- Bifidobacterium
- Streptococcus Thermophilus
- Yeast
- Liquid
- Dry
- Functional Food and Beverages
- Dietary Supplements
- Animal Feed
- Human
- Animal
Table of Contents
Companies Mentioned
- Aliment Ltd
- BELLAVIE srl
- Lallemand
- Natren UK
- Nestlé
- Pfizer Inc.
- Protexin
- ProVen Probiotics
- Wren Laboratories
- Yakult

